Is Aurora Cannabis Inc. (ACB) a Buy, Sell, or Hold?
Aurora Cannabis Inc.
NASDAQ:ACB
$2.66 USD
-$0.01 (-0.37%)
- Volume
- 1.09M
- Average Volume
- 1.2M
- Market Capitalization
- $164.77M
- P/E Ratio
- -1.68
- Dividend Yield
- 0.00%
- Price Target
- $8.00
- Year High
- $6.67
- Year Low
- $2.62
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.94
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Miguel Martin |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | ACB |
| CUSIP | 05156X850 |
| CIK | 0001683541 |
| Web | https://www.auroramj.com |
| Phone | 16043625207 |
| Currency | USD |
| Employees | 1028 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.05 |
| Payout Ratio | 0.00 |
| Current Ratio | 5.94 |
| Quick Ratio | 3.32 |
| Cash Ratio | 1.68 |
Sales & Book Value
| Annual Sales | $320.59M |
| Price / Sales | 0.74 |
| Cash Flow | -0.63 |
| Price / Cash Flow | -6.42 |
| Price / Book | 0.42 |
Price Target and Rating
| Average Stock Price Forecast | $8.00 |
| High Stock Price Forecast | $8.75 |
| Low Stock Price Forecast | $1.00 |
| Forecast Upside/Downside | -66.75% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 14 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-2.15 |
| Trailing P/E Ratio | -1.68 |
| PEG Ratio | -0.02 |
| P/E Growth | -0.02 |
| Net Income | $-135.96M |
| Net Margin | -24.14% |
| Pretax Margin | -1.62% |
| Return on Equity | -14.05% |
| Return on Assets | -12.45% |
Financials Score
| AltmanZ Score | -12.39 |
| Piotroski Score | 5.00 |
| Working Capital | 331.38M |
| Total Assets | 602.64M |
| Ebit | -29.12M |
| Market Cap | 237.61M |
| Total Liabilities | 89.49M |
Poll Results
About Aurora Cannabis Inc. (NASDAQ:ACB) Stock
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporiz ... ers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Aurora Named to TIME Canada's Best Companies 2026 List
2026-07-09 16:05:00
NASDAQ | TSX: ACB The Company makes history as the first and only cannabis company to ever receive this recognition EDMONTON, AB, July 9, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, has been awarded on TIME Canada's Best Companies 2026 list. This win reflects the Company's differentiated performance and commitment to industry excellence.
2026-07-08 07:15:00
Shareholders are encouraged to keep an eye out for their meeting materials and vote early – every vote matters, no matter how many shares you own. Shareholders who have questions or need assistance with voting their shares voting should contact Aurora's strategic advisor and proxy solicitation agent, Kingsdale Advisors by telephone at 1-800-749-9052 or by email at [email protected] or visit www.MyAuroraVote.com EDMONTON, AB, July 8, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSX: ACB) (NASDAQ: ACB), a leading Canada-based global medical cannabis company, is pleased to announce that the management information circular (the "Circular") for the upcoming annual general meeting of shareholders is now available on the Company's website at www.auroramj.com/investors/corporate-governance as well as under its profile on SEDAR+ (www.sedarplus.ca).
Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs
2026-06-12 10:21:06
ACB frames fiscal 2027 as a reset year as Canadian reimbursement pressure weighs on margins, even as global medical cannabis growth continues.
Aurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - Buy
2026-06-12 04:26:49
Aurora Cannabis reported Q4/FY2026 results largely in line with expectations previously outlined by management. In recent months, the company has made the strategic decision to exit its lower margin consumer cannabis and plant propagation operations and focus on the growing European medical cannabis market. However, FY2027 will be impacted by adverse regulatory changes in the Canadian medical cannabis market. As a result, sales and margins are expected to decline quite meaningfully this year.
Aurora Cannabis Q4 Earnings Call Highlights
2026-06-11 09:04:17
Aurora Cannabis NASDAQ: ACB reported a stronger fiscal 2026 performance than it had forecast, driven by growth in global medical cannabis, while warning that fiscal 2027 will be a “reset year” as Canadian medical reimbursement changes weigh on revenue and margins.
2026-06-11 07:05:00
NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue1 of $288.6 million, representing 18% YoY growth Delivers Record Annual Adjusted EBITDA 1 of $53.8 million, representing 32% YoY growth Completes Accretive Acquisition of Safari Flower Company in April, an established EU-GMP Manufacturer, adding Critical Capacity to Serve Growing Profitable International Markets Maintains Strong Balance Sheet with ~$164.7 million of Cash, Short Term Investments and Cash Equivalents2 with no Debt EDMONTON, AB, June 11, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2026 periods ending March 31, 2026. "During fiscal year 2026, we exceeded our projection for global medical cannabis net revenue1 led by double-digit growth in Europe and delivered on our expectation for Adjusted EBITDA1 with both at record outcomes.
2026-06-07 07:17:48
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Aurora Deepens its Impact for Veterans Across Canada
2026-06-02 07:07:00
NASDAQ | TSX: ACB From global leadership to local impact, Aurora continues to support Veteran-focused programs across Canada, addressing food security, mental health, and community engagement EDMONTON, AB, June 2, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, shares recent contributions through its Strains for Heroes program, expanding support for Veteran communities across Canada. Aurora's ongoing commitment to support Veterans includes five per cent of net profits from the sale of Strains for Heroes products being donated annually to veteran-focused organizations, up to a maximum of C$200,000.
Frequently Asked Questions
-
What is the current Aurora Cannabis Inc. (ACB) stock price?
-
Aurora Cannabis Inc.(NASDAQ:ACB) stock price is $2.66 in the last trading session. During the trading session, ACB stock reached the peak price of $6.665 while $2.62 was the lowest point it dropped to. The percentage change in ACB stock occurred in the recent session was --0.37% while the dollar amount for the price change in ACB stock was -$-0.01.
-
ACB's industry and sector of operation?
-
The NASDAQ listed ACB is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of ACB?
-
Kevin Niland | Senior Director of Strategic Finance - Global FP&A and Investor Relations
Kerry Miller | Managing Director for Australia & New Zealand
Nathalie Clark | Executive Vice President, General Counsel & Corporate Secretary
Alex Miller | Executive Vice President of Operations & Supply Chain
David Aird | Executive Vice President of Information Technology -
How many employees does ACB have?
-
Number of ACB employees currently stands at 1028. ACB operates from 500 - 10355 Jasper Avenue, Edmonton, AB T5J 1Y6, CA.
-
Link for ACB official website?
-
Official Website of ACB is: https://www.auroramj.com
-
How do I contact ACB?
-
ACB could be contacted at phone #16043625207 and can also be accessed through its website. ACB operates from 500 - 10355 Jasper Avenue, Edmonton, AB T5J 1Y6, CA.
-
How many shares of ACB are traded daily?
-
The average number of ACB shares traded daily for last 3 months was 1.2M.
-
What is the market cap of ACB currently?
-
The market value of ACB currently stands at $164.77M with its latest stock price at $2.66